David A. Morrow, M.D. and Elliott M. Antman, M.D.

Dr. Morrow is Fellow in Cardiovascular Medicine, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School. Dr. Antman is Associate Professor of Medicine, Harvard Medical School, Director, Coronary Care Unit, Brigham and Women's Hospital, Boston, MA.

Drs. Morrow and Antman report no commercial conflict of interest.

Release Date: 05/19/1999
Termination Date: 05/19/2002

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Describe the individual advantages and disadvantages of each of the major markers of myocardial necrosis in the diagnosis of acute myocardial infarction
• Discuss the prognostic capacity of the cardiac specific troponins among patients with chest pain suspicious for myocardial infarction
• Outline the potential future uses of novel cardiac markers in the evaluation, triage and treatment of patients with acute coronary syndromes.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity